Vaccine News and Research

Latest Vaccine News and Research

Study shows only 75.8% of children under 15 have antibodies against measles

Study shows only 75.8% of children under 15 have antibodies against measles

1 Dec 2022
Risk factor assessment for the development of severe SARS-CoV-2 breakthrough infections

Risk factor assessment for the development of severe SARS-CoV-2 breakthrough infections

1 Dec 2022
Are medical masks non-inferior to N95 respirators to prevent COVID-19 in health care workers providing routine care?

Are medical masks non-inferior to N95 respirators to prevent COVID-19 in health care workers providing routine care?

1 Dec 2022
Novel prefusion S antigen designed by the mutation of the SARS-CoV-2 Spike protein’s trimeric structure

Novel prefusion S antigen designed by the mutation of the SARS-CoV-2 Spike protein’s trimeric structure

1 Dec 2022
The requirement for Fc effector functions to protect against SARS-CoV-2 infection

The requirement for Fc effector functions to protect against SARS-CoV-2 infection

1 Dec 2022
Study provides a framework to guide the development of variant-resistant SARS-CoV-2 vaccines

Study provides a framework to guide the development of variant-resistant SARS-CoV-2 vaccines

30 Nov 2022
SARS-CoV-2 can cause hyperglycemia in cats

SARS-CoV-2 can cause hyperglycemia in cats

30 Nov 2022
More than half of U.S. adults weren’t concerned about the flu season, survey shows

More than half of U.S. adults weren’t concerned about the flu season, survey shows

30 Nov 2022
Phase 2/3 clinical trial shows that Clover’s vaccine candidate reduces household transmission of SARS-CoV-2

Phase 2/3 clinical trial shows that Clover’s vaccine candidate reduces household transmission of SARS-CoV-2

30 Nov 2022
Study on mpox epidemiology in New York during summer 2022

Study on mpox epidemiology in New York during summer 2022

30 Nov 2022
Australian researchers unearth a new form of antimicrobial resistance

Australian researchers unearth a new form of antimicrobial resistance

30 Nov 2022
Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants

Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants

30 Nov 2022
Zika-exposed children may show differences in cognitive development, mood and mobility

Zika-exposed children may show differences in cognitive development, mood and mobility

30 Nov 2022
Fragment crystallizable receptor-effector functions as a key correlate for pan-sarbecovirus vaccine development

Fragment crystallizable receptor-effector functions as a key correlate for pan-sarbecovirus vaccine development

30 Nov 2022
Broadly cross-reactive antibodies that protect from SARS-CoV-2 variants are revealed by virus coldspot-driven discovery

Broadly cross-reactive antibodies that protect from SARS-CoV-2 variants are revealed by virus coldspot-driven discovery

30 Nov 2022
The antibody resistance profile and viral receptor binding affinity of SARS-CoV-2 Omicron BQ.1, BQ.1.1, XBB, and XBB.1 subvariants

The antibody resistance profile and viral receptor binding affinity of SARS-CoV-2 Omicron BQ.1, BQ.1.1, XBB, and XBB.1 subvariants

30 Nov 2022
Miracles Start in the Lab: The quest to find a vaccine to cure AIDS

Miracles Start in the Lab: The quest to find a vaccine to cure AIDS

30 Nov 2022
Monkeypox renamed "mpox" in an effort to combat stigma

Monkeypox renamed "mpox" in an effort to combat stigma

29 Nov 2022
COVID-19 pandemic fatigue in Hong Kong

COVID-19 pandemic fatigue in Hong Kong

29 Nov 2022
Engineered proteins can be delivered as a nasal spray to protect against and treat COVID-19

Engineered proteins can be delivered as a nasal spray to protect against and treat COVID-19

29 Nov 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback